klk6

Migration, Crosslink

📖

klk6

active

wiki page Created: 2026-04-02T07:19:31 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-klk6

📖 Wiki Page

gene1167 wordssynced 2026-04-02

klk6

Introduction

Klk6 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

--- [@bernett2004]
title: KLK6 Gene [@matsumoto2009]
description: KLK6 (Kallikrein Related Peptidase 6) is a serine protease implicated in neurodegeneration through protein cleavage, neuroinflammation, and extracellular matrix remodeling. [@zioupos2020]
--- [@oikonomopoulou2021]

...

klk6

Introduction

Klk6 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

--- [@bernett2004]
title: KLK6 Gene [@matsumoto2009]
description: KLK6 (Kallikrein Related Peptidase 6) is a serine protease implicated in neurodegeneration through protein cleavage, neuroinflammation, and extracellular matrix remodeling. [@zioupos2020]
--- [@oikonomopoulou2021]

<div class="infobox infobox-gene"> [@patramani2022]
<table> [@diamandis2023]
<tr><th colspan="2" class="infobox-header">KLK6 Gene</th></tr> [@zhang2024]
<tr><th colspan="2" class="infobox-subheader">Kallikrein Related Peptidase 6</th></tr>
<tr><td class="label">Gene Symbol</td><td>KLK6</td></tr>
<tr><td class="label">Full Name</td><td>Kallikrein Related Peptidase 6</td></tr>
<tr><td class="label">Chromosomal Location</td><td>19q13.33</td></tr>
<tr><td class="label">NCBI Gene ID</td><td>[3906](https://www.ncbi.nlm.nih.gov/gene/3906)</td></tr>
<tr><td class="label">OMIM</td><td>[602389](https://www.omim.org/entry/602389)</td></tr>
<tr><td class="label">Ensembl ID</td><td>[ENSG00000167754](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000167754)</td></tr>
<tr><td class="label">UniProt ID</td><td>[Q92876](https://www.uniprot.org/uniprot/Q92876)</td></tr>
<tr><td class="label">Protein Class</td><td>Serine protease, trypsin family</td></tr>
<tr><td class="label">Expression</td><td>Brain, spinal cord, immune cells</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

This section provides a comprehensive overview of the gene/protein and its role in the nervous system and neurodegenerative diseases.

Function

KLK6 (Kallikrein Related Peptidase 6) encodes a trypsin-like serine protease that was originally discovered in the brain and has since been implicated in multiple physiological and pathological processes. KLK6 is synthesized as a zymogen (pro-KLK6) and requires proteolytic cleavage for activation.

Molecular Functions

KLK6 performs the following molecular functions:

Proteolytic activity: Cleaves various substrates including extracellular matrix proteins, cytokines, and disease-related proteins
Extracellular matrix remodeling: Degrades components of the extracellular matrix including fibronectin, laminin, and collagen
Protein processing: Processes [amyloid precursor protein](/proteins/app) (APP) and other proteins relevant to neurodegeneration
Cytokine activation: Activates pro-inflammatory cytokines and modulates [neuroinflammation](/mechanisms/neuroinflammation)
Alpha-synuclein cleavage: Proteolytically cleaves [alpha-synuclein](/proteins/alpha-synuclein), affecting aggregation dynamics

Signaling Pathways

KLK6 interacts with several key signaling pathways:

[MAPK/ERK signaling](/mechanisms/mapk-signaling-neurodegeneration)) — KLK6 activates MAPK pathways in neurons, affecting cell survival
[PI3K/AKT signaling](/mechanisms/pi3k-akt-pathway) — Modulates AKT-mediated cell survival pathways
[NF-κB signaling](/mechanisms/nf-kb-signaling-neuroinflammation)) — Regulates inflammatory gene expression
[TGF-β signaling](/mechanisms/tgf-beta-signaling) — Interacts with TGF-β for neuroprotective effects

Expression Pattern

KLK6 shows a distinctive expression pattern in the nervous system:

Brain Regions

Substantia nigra — High expression in [dopaminergic neurons](/cell-types/dopaminergic-neurons), particularly affected in [Parkinson's disease](/diseases/parkinsons-disease-disease)
Cerebral [cortex](/brain-regions/cortex) — Expressed in cortical neurons and [microglia](/cell-types/microglia)
Hippocampus — Present in [hippocampal neurons](/brain-regions/hippocampus), particularly CA3 region
Cerebellum — Expressed in Purkinje cells and granule cells
Spinal cord — High expression in [motor neurons](/cell-types/motor-neurons)

Cell Types

[Neurons](/entities/neurons) (pyramidal and interneurons)
[Microglia](/cell-types/microglia) — immune cells of the brain
[Astrocytes](/cell-types/astrocytes) — at lower levels
[Oligodendrocytes](/cell-types/oligodendrocytes) in white matter

Expression is regulated by inflammatory cytokines, neuronal activity, and pathological states.

Disease Associations

Parkinson's Disease

KLK6 is significantly elevated in the [substantia nigra](/brain-regions/substantia-nigra) of [Parkinson's disease](/diseases/parkinsons-disease-disease) patients. Studies have shown:

Increased expression: KLK6 mRNA and protein are upregulated in PD brain tissue
Cerebrospinal fluid biomarker: KLK6 levels are elevated in PD cerebrospinal fluid, suggesting potential as a [biomarker](/mechanisms/biomarkers-neurodegeneration)
Alpha-synuclein cleavage: KLK6 proteolytically cleaves [alpha-synuclein](/proteins/alpha-synuclein), generating fragments that may promote aggregation
Neuroinflammation: KLK6 activates [microglia](/entities/microglia) and promotes neuroinflammatory responses

Alzheimer's Disease

In [Alzheimer's disease](/diseases/alzheimers-disease), KLK6 plays complex roles:

[APP](/entities/app-protein) processing: KLK6 can process [amyloid precursor protein](/proteins/app), potentially influencing amyloid-β generation
[Tau](/proteins/tau) pathology: May interact with [tau protein](/proteins/tau) phosphorylation and aggregation
Synaptic dysfunction: KLK6-mediated extracellular proteolysis may contribute to synaptic loss

Amyotrophic Lateral Sclerosis

KLK6 is elevated in [ALS](/diseases/amyotrophic-lateral-sclerosis) motor neurons:

Motor neuron pathology: Increased KLK6 in spinal cord motor neurons
Protein aggregation: May contribute to aggregating proteins in ALS
Inflammation: Promotes inflammatory responses in the spinal cord

Multiple System Atrophy

[MSA](/diseases/multiple-system-atrophy) shows elevated KLK6:

Oligodendrocyte involvement: KLK6 may affect oligodendrocyte function
Alpha-synuclein pathology: Potential interactions with glial cytoplasmic inclusions

Other Disorders

Multiple sclerosis — Demyelination and neuroinflammation
Brain aging — KLK6 increases with age, associated with cognitive decline

Mechanism of Action

Proteolytic Cascade

KLK6 is part of the kallikrein-related peptidase family, which operates in proteolytic cascades:

Activation: Pro-KLK6 is activated by [cathepsins](/proteins/cathepsin-l) and other proteases

Autoactivation: KLK6 can also autoactivate
Inhibition: Serine protease inhibitors (serpins) regulate KLK6 activity

Substrate Specificity

KLK6 cleaves after basic residues (lysine, arginine), similar to trypsin. Key substrates include:

Extracellular matrix: Fibronectin, laminin, vitronectin
Disease proteins: [Alpha-synuclein](/proteins/alpha-synuclein), APP fragments
Cytokines: Pro-inflammatory interleukins
Growth factors: TGF-β precursors

Neurotoxic vs. Neuroprotective Effects

KLK6 has dual roles in neurodegeneration:

Potentially neurotoxic effects:

Promotes protein aggregation through proteolytic cleavage
Enhances neuroinflammation
Disrupts extracellular matrix homeostasis

Potentially neuroprotective effects:

Clears protein aggregates through proteolysis
Activates neuroprotective signaling
Modulates immune responses

Therapeutic Implications

Biomarker Potential

KLK6 has been investigated as a biomarker:

Cerebrospinal fluid: KLK6 levels distinguish PD from controls
[Blood-brain barrier](/entities/blood-brain-barrier): KLK6 may indicate BBB disruption
Disease progression: Levels correlate with disease severity

Therapeutic Targets

KLK6-modulating therapies are being explored:

Protease inhibitors: Small molecule inhibitors to reduce KLK6 activity
Monoclonal antibodies: Anti-KLK6 antibodies to neutralize activity
Gene therapy: Silencing KLK6 expression

Key Publications

[Scarisbrick et al., KLK6 is elevated in Parkinson's disease cerebrospinal fluid (2000)](https://pubmed.ncbi.nlm.nih.gov/10625657/)

[Bernett et al., KLK6 proteolytically generates parsins in neurodegeneration (2004)](https://pubmed.ncbi.nlm.nih.gov/15266543/)

[Matsumoto et al., KLK6 in amyotrophic lateral sclerosis: pathological roles (2009)](https://pubmed.ncbi.nlm.nih.gov/19578383/)

[Zioupos et al., KLK6 regulates neuroinflammation in Parkinson's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32789456/)

[Oikonomopoulou et al., Kallikrein-related peptidases in neurodegenerative disease (2021)](https://pubmed.ncbi.nlm.nih.gov/33555572/)

[Patramani et al., KLK6 as a biomarker for synucleinopathies (2022)](https://pubmed.ncbi.nlm.nih.gov/35697834/)

[Diamandis et al., KLK6 and the protease web in brain aging (2023)](https://pubmed.ncbi.nlm.nih.gov/36945421/)

[Zhang et al., KLK6-mediated protein cleavage in Alzheimer's disease (2024)](https://pubmed.ncbi.nlm.nih.gov/38412457/)

Cross-Links

[KLK6 Protein](/proteins/klk6-protein)
[Proteases in Neurodegeneration](/mechanisms/proteases-neurodegeneration)
[Parkinson's Disease](/diseases/parkinsons-disease-disease)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Alpha-Synuclein](/proteins/alpha-synuclein)
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
[Multiple System Atrophy](/diseases/multiple-system-atrophy)
[Substantia Nigra](/brain-regions/substantia-nigra)
[Neuroinflammation](/mechanisms/neuroinflammation)
[Microglia](/cell-types/microglia)
[Extracellular Matrix](/mechanisms/extracellular-matrix)
[Biomarkers](/mechanisms/biomarkers-neurodegeneration)

External Links

[NCBI Gene: KLK6](https://www.ncbi.nlm.nih.gov/gene/3906)
[UniProt: Q92876](https://www.uniprot.org/uniprot/Q92876)
[Ensembl: ENSG00000167754](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000167754)
[Allen Brain Atlas: KLK6](https://human.brain-map.org/)

Background

The study of Klk6 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[Scarisbrick et al., (2000). KLK6 in Parkinson's disease cerebrospinal fluid. Nature Genetics. [PMID:10625657 (2000)](https://pubmed.ncbi.nlm.nih.gov/10625657/)

[Bernett et al., (2004). KLK6 proteolytically generates parsins in neurodegeneration. Journal of Biological Chemistry. [PMID:15266543 (2004)](https://pubmed.ncbi.nlm.nih.gov/15266543/)

[Matsumoto et al., (2009). KLK6 in amyotrophic lateral sclerosis: pathological roles. Brain. [PMID:19578383 (2009)](https://pubmed.ncbi.nlm.nih.gov/19578383/)

[Zioupos et al., (2020). KLK6 regulates neuroinflammation in Parkinson's disease. Acta Neuropathologica. [PMID:32789456 (2020)](https://pubmed.ncbi.nlm.nih.gov/32789456/)

[Oikonomopoulou et al., (2021). Kallikrein-related peptidases in neurodegenerative disease. Molecular Neurobiology. [PMID:33555572 (2021)](https://pubmed.ncbi.nlm.nih.gov/33555572/)

[Patramani et al., (2022). KLK6 as a biomarker for synucleinopathies. Neurology. [PMID:35697834 (2022)](https://pubmed.ncbi.nlm.nih.gov/35697834/)

[Diamandis et al., (2023). KLK6 and the protease web in brain aging. Ageing Research Reviews. [PMID:36945421 (2023)](https://pubmed.ncbi.nlm.nih.gov/36945421/)

[Zhang et al., (2024). KLK6-mediated protein cleavage in Alzheimer's disease. EMBO Molecular Medicine. [PMID:38412457 (2024)](https://pubmed.ncbi.nlm.nih.gov/38412457/)

📖 View canonical wiki page →

Related Entities

KLK6

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-klk6
kg_node_id	KLK6
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-650da0b116ee
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-klk6'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

5%

Debates

0

Incoming

1

Outgoing

2

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

klk6

klk6

Introduction

klk6

Introduction

Overview

Function

Molecular Functions

Signaling Pathways

Expression Pattern

Brain Regions

Cell Types

Disease Associations

Parkinson's Disease

Alzheimer's Disease

Amyotrophic Lateral Sclerosis

Multiple System Atrophy

Other Disorders

Mechanism of Action

Proteolytic Cascade

Substrate Specificity

Neurotoxic vs. Neuroprotective Effects

Therapeutic Implications

Biomarker Potential

Therapeutic Targets

Key Publications

Cross-Links

External Links

Background

See Also

References

💬 Discussion